Compare ASND & TTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASND | TTD |
|---|---|---|
| Founded | 2006 | 2009 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6B | 13.0B |
| IPO Year | 2014 | 2016 |
| Metric | ASND | TTD |
|---|---|---|
| Price | $225.73 | $27.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 35 |
| Target Price | ★ $278.80 | $50.88 |
| AVG Volume (30 Days) | 713.8K | ★ 17.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.38 |
| EPS | N/A | ★ 0.90 |
| Revenue | N/A | ★ $2,896,284,000.00 |
| Revenue This Year | $98.02 | $14.42 |
| Revenue Next Year | $43.13 | $12.91 |
| P/E Ratio | ★ N/A | $29.48 |
| Revenue Growth | N/A | ★ 18.47 |
| 52 Week Low | $124.06 | $21.08 |
| 52 Week High | $248.60 | $91.45 |
| Indicator | ASND | TTD |
|---|---|---|
| Relative Strength Index (RSI) | 46.01 | 48.09 |
| Support Level | $190.49 | $21.08 |
| Resistance Level | $229.94 | $28.54 |
| Average True Range (ATR) | 9.30 | 1.54 |
| MACD | -1.48 | 0.53 |
| Stochastic Oscillator | 21.99 | 51.75 |
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on devices like computers, smartphones, and connected TVs. It uses data in an iterative manner to optimize the performance of ad impressions purchased. The firm's platform is referred to as a demand-side platform in the digital ad industry, and it generates revenue from fees based on a percentage of what its clients spend on advertising.